Corrigendum to Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessment

Affiliations

• ¹ Safer Medicines Trust, Kingsbridge, UK.
• ² Animal Free Research UK, London, UK.
• ³ Viveo Consulting Ltd, London, UK.
• ⁴ Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, London, UK.
• ⁵ College of Health and Life Sciences, Aston University, Birmingham, UK.
• ⁶ CN Bio Innovations Limited, Cambridge, UK.
• ⁷ University of Exeter Medical School, Exeter, UK.
• ⁸ ImmuONE Limited, Hatfield, UK; Centre for Topical Drug Delivery and Toxicology, University of Hertfordshire, Hatfield, UK.
• ⁹ Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
• ¹⁰ Austrian Institute of Technology GmbH, Competence Unit Molecular Diagnostics, Vienna, Austria; Department of Medicine, Danube Private University, Krems, Austria.
• ¹¹ Roper Toxicology Consulting Limited, Edinburgh, UK.
• ¹² Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.
• ¹³ Newcells Biotech, Newcastle upon Tyne, UK.
• ¹⁴ Cruelty Free International, London, UK.